| Dr Mahta Mortezavi, MD | |
|
222 Alexander St Ste 3000, Rochester, NY 14607-4047 | |
| (585) 922-8350 | |
| Not Available |
| Full Name | Dr Mahta Mortezavi |
|---|---|
| Gender | Female |
| Speciality | Internal Medicine - Allergy & Immunology |
| Location | 222 Alexander St Ste 3000, Rochester, New York |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1093013781 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207RR0500X | Internal Medicine - Rheumatology | 282225 (New York) | Secondary |
| 207RA0201X | Internal Medicine - Allergy & Immunology | 282225 (New York) | Primary |
| Entity Name | Rochester General Hospital |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1356412712 PECOS PAC ID: 0244149474 Enrollment ID: O20031121000644 |
News Archive
Numerous radiology practices were able to significantly reduce the radiation dose associated with multi-detector computed tomography (MDCT) scans by participating in a one day dose optimization workshop provided by the Royal Australian and New Zealand College of Radiologists and supported by the local state health department, according to a study in the August issue of the Journal of the American College of Radiology.
Researchers at the University of Copenhagen have identified a new prognostic biomarker: the neuropeptide pro-NPY, which may help determine the risk of dying from prostate cancer. This particular type of protein is very specific to prostate cancer cells and could help identify whether newly diagnosed patients require radical prostatectomy surgery or if it is safe to delay surgery.
Numerous studies have shown that monitoring physical activity promotes better health – from reducing body mass index to watching for signs of hypertension, for example. A new study suggests step counters could play yet another role: predicting outcomes for people undergoing chemoradiation therapy for lung cancer.
A pill that suppresses a key regulator of cancer growth may provide hope to relapsed leukemia and lymphoma patients running out of treatment options for their aggressive, treatment-resistant disease, according to three reports published online today in Blood, the journal of the American Society of Hematology.
The link between mental health disorders and substance abuse is well-documented. Nearly one in 12 adults in the U.S is depressed, and opioid-related deaths are skyrocketing. As these numbers continue to climb, some mental health professionals have started to wonder if there's a link between the two.
› Verified 7 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Mahta Mortezavi, MD 222 Alexander St, Ste 3000, Rochester, NY 14607-4047 Ph: (585) 922-8350 | Dr Mahta Mortezavi, MD 222 Alexander St Ste 3000, Rochester, NY 14607-4047 Ph: (585) 922-8350 |
News Archive
Numerous radiology practices were able to significantly reduce the radiation dose associated with multi-detector computed tomography (MDCT) scans by participating in a one day dose optimization workshop provided by the Royal Australian and New Zealand College of Radiologists and supported by the local state health department, according to a study in the August issue of the Journal of the American College of Radiology.
Researchers at the University of Copenhagen have identified a new prognostic biomarker: the neuropeptide pro-NPY, which may help determine the risk of dying from prostate cancer. This particular type of protein is very specific to prostate cancer cells and could help identify whether newly diagnosed patients require radical prostatectomy surgery or if it is safe to delay surgery.
Numerous studies have shown that monitoring physical activity promotes better health – from reducing body mass index to watching for signs of hypertension, for example. A new study suggests step counters could play yet another role: predicting outcomes for people undergoing chemoradiation therapy for lung cancer.
A pill that suppresses a key regulator of cancer growth may provide hope to relapsed leukemia and lymphoma patients running out of treatment options for their aggressive, treatment-resistant disease, according to three reports published online today in Blood, the journal of the American Society of Hematology.
The link between mental health disorders and substance abuse is well-documented. Nearly one in 12 adults in the U.S is depressed, and opioid-related deaths are skyrocketing. As these numbers continue to climb, some mental health professionals have started to wonder if there's a link between the two.
› Verified 7 days ago
Amy Bodrog, MD Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 1425 Portland Ave, Rochester, NY 14621 Phone: 585-922-4020 Fax: 585-922-4622 | |
Natalia Golub, MD Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 30 Hagen Dr Ste 320, Rochester, NY 14625 Phone: 585-922-1900 | |
Hanan Ibrahim Sheikh Ibrahim, MD Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 1415 Portland Ave Ste 200, Rochester, NY 14621 Phone: 585-922-0390 Fax: 585-922-0395 | |
Numra Aslam Bajwa, MD Internal Medicine Medicare: Medicare Enrolled Practice Location: 1425 Portland Ave, Rochester, NY 14621 Phone: 585-922-5067 Fax: 716-862-1871 | |
Dr. Prakash Upreti, MD Internal Medicine Medicare: Medicare Enrolled Practice Location: 1425 Portland Ave, Rochester, NY 14621 Phone: 295-029-8769 | |
William M Valenti, MD Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 259 Monroe Avenue, Rochester, NY 14607 Phone: 585-545-7200 Fax: 585-244-6456 | |
Ms. Terri Winter, N.P. Internal Medicine Medicare: Not Enrolled in Medicare Practice Location: 250 Crittenden Blvd, Box 617, Rochester, NY 14642 Phone: 585-275-2662 Fax: 585-276-0149 |